Summary Termination. 19.1 The Company is entitled to terminate the Appointment by summary notice in writing and without payment in lieu of notice if you: 19.1.1 are guilty of any gross misconduct affecting the business of any Group Company; 19.1.2 commit any serious breach or repeated or continued (after warning) any material breach of your obligations under this Contract; 19.1.3 commit (by commission or omission) any act which brings or would tend to bring the Company or any Group Company into disrepute; 19.1.4 fail to perform your duties to a satisfactory standard after having received a written warning from the Company relating to the same; 19.1.5 are guilty of any dishonesty, gross misconduct or wilful neglect of duty; 19.1.6 damage Company property maliciously; 19.1.7 falsify attendance or sickness or other records; 19.1.8 falsify any data during the course of your employment; 19.1.9 conduct yourself in a manner materially adverse to the interests of the Company or any Group Company; 19.1.10 are, in the reasonable opinion of the Board, negligent and incompetent in the performance of your duties; 19.1.11 have a bankruptcy order made against you or enter into a voluntary arrangement within the meaning of section 253 Insolvency ▇▇▇ ▇▇▇▇; 19.1.12 consume or distribute narcotics on Company premises; 19.1.13 are convicted of any criminal offence (other than an offence under any road traffic legislation in the United Kingdom or elsewhere for which a fine or non-custodial penalty is imposed) whether or not in the course of your employment; 19.1.14 are, in the opinion of a medical practitioner who is treating you, physically or mentally incapable of performing your duties and may remain so for more than three months and the medical practitioner has given a medical opinion to the Board to that effect; 19.1.15 cease to be eligible to work in the United Kingdom; 19.1.16 knowingly commit any deliberate act which amounts to discrimination, victimisation or harassment on any unlawful ground; 19.1.17 are in breach of the Company’s anti-corruption and bribery policy and related procedures; 19.1.18 are guilty of a serious breach of any rules issued by the Company from time to time regarding its electronic communications systems; 19.1.19 are unable by reason of Incapacity to perform his duties under this Contract for an aggregate period of 26 weeks in any 52-week period; or 19.1.20 commit any other offence of a similar gravity to the examples under this clause 19.1, which are neither exclusive nor exhaustive. 19.2 Any delay by the Company in exercising such right of termination shall not constitute a waiver of that right. 19.3 The termination by the Company of the Appointment pursuant to this clause 19 will be without prejudice to any claim that the Company may have for damages arising from any breach of this Contract by you that gives rise to such termination.
Appears in 11 contracts
Sources: Employment Agreement (Mereo Biopharma Group PLC), Employment Agreement (Mereo Biopharma Group PLC), Employment Agreement (Mereo Biopharma Group PLC)
Summary Termination. 19.1 The Company is entitled to terminate the Appointment by summary notice in writing and without payment in lieu of notice for Cause, meaning if you:
19.1.1 are guilty of any gross misconduct affecting the business of any Group Company;
19.1.2 commit any serious breach or repeated or continued (after warning) any material breach of your obligations under this Contract;
19.1.3 commit (by commission or omission) any act which brings or would tend to bring the Company or any Group Company into disrepute;
19.1.4 fail to perform your duties to a satisfactory standard after having received a written warning from the Company relating to the same;
19.1.5 are guilty of any dishonesty, gross misconduct or wilful neglect of duty;
19.1.6 damage Company property maliciously;
19.1.7 falsify attendance or sickness or other records;
19.1.8 falsify any data during the course of your employment;
19.1.9 conduct yourself in a manner materially adverse to the interests of the Company or any Group Company;
19.1.10 are, in the reasonable opinion of the Board, negligent and incompetent in the performance of your duties;
19.1.11 have a bankruptcy order made against you or enter into a voluntary arrangement within the meaning of section 253 Insolvency ▇▇▇ ▇▇▇▇;
19.1.12 consume or distribute narcotics on Company premises;
19.1.13 are convicted of any criminal offence (other than an offence under any road traffic legislation in the United Kingdom or elsewhere for which a fine or non-custodial penalty is imposed) whether or not in the course of your employment;
19.1.14 are, in the opinion of a medical practitioner who is treating you, physically or mentally incapable of performing your duties and may remain so for more than three months and the medical practitioner has given a medical opinion to the Board to that effect;
19.1.15 cease to be eligible to work in the United Kingdom;
19.1.16 knowingly commit any deliberate act which amounts to discrimination, victimisation or harassment on any unlawful ground;
19.1.17 are in breach of the Company’s anti-corruption and bribery policy and related procedures;
19.1.18 are guilty of a serious breach of any rules issued by the Company from time to time regarding its electronic communications systems;
19.1.19 are unable by reason of Incapacity to perform his duties under this Contract for an aggregate period of 26 weeks in any 52-week period; or
19.1.20 commit any other offence of a similar gravity to the examples under this clause 19.1, which are neither exclusive nor exhaustive.
19.2 Any delay by the Company in exercising such right of termination shall not constitute a waiver of that right.
19.3 The termination by the Company of the Appointment pursuant to this clause 19 will be without prejudice to any claim that the Company may have for damages arising from any breach of this Contract by you that gives rise to such termination.
Appears in 6 contracts
Sources: Contract of Employment (Mereo Biopharma Group PLC), Contract of Employment (Mereo Biopharma Group PLC), Contract of Employment (Mereo Biopharma Group PLC)